FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a medication for the complex therapy of patients with type 2 diabetes mellitus and a method of the complex therapy of patients with type 2 diabetes mellitus. The medication for the complex therapy of patients with type 2 diabetes mellitus contains a cleaned and dried rhizome of Curcuma longa in the form of powder with the specified size of particles. The method of the complex therapy of patients with type 2 diabetes mellitus consists of the daily intake of the cleaned and dried rhizome of Curcuma longa in the form of powder with the specified size of particles twice per day after dinner and supper at the background of the intake of pelleted hypoglycaemic agents without changing the dose and scheme of the drug therapy.
EFFECT: medication produces a direct stimulating impact on β-cells of the pancreas and ensures the development of a hypoglycaemic effect, including early stages of the disease development.
3 cl, 1 dwg, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION BASED ON TURMERIC FOR TREATING DIABETES MELLITUS, PRODUCTION AND USE THEREOF | 2021 |
|
RU2768734C1 |
ANTIDIABETIC AGENT WITH HYPOLIPIDEMIC ACTIVITY FOR TREATMENT AND PREVENTION OF INSULAR DIABETES II TYPE | 2007 |
|
RU2337698C1 |
COMPOSITION POSSESSING ANTIDIABETIC ACTION | 2015 |
|
RU2611353C2 |
ANTIDIABETIC AGENT | 2001 |
|
RU2195300C1 |
MEDICINAL PRODUCT FOR DIABETES TREATMENT | 2006 |
|
RU2329813C2 |
MEANS FOR TREATING DIABETES | 2000 |
|
RU2165767C1 |
ANTIDIABETIC AGENT | 2001 |
|
RU2197259C1 |
TETRAPEPTIDE REGULATING GLUCOSE LEVEL IN DIABETES MELLITUS, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD FOR ITS APPLYING | 2003 |
|
RU2242241C1 |
BIOLOGICALLY ACTIVE FOOD SUPPLEMENT | 2021 |
|
RU2785953C2 |
AGENT POSSESSING ANTIDIABETIC ACTIVITY | 2006 |
|
RU2313361C1 |
Authors
Dates
2015-04-20—Published
2012-10-24—Filed